133 results
Page 5 of 7
424B5
vldxu
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
sm5u gaxyi8gj7
7 Dec 20
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
s6c07 7xcd7
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
jyl2a5y
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
EX-99.2
g4qeqg3t
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
5y9hg2k6aegkte30h4uy
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
3py8uh
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
2k2n7di34qd0ad5ifxxo
5 Nov 20
Sutro Biopharma Reports Third Quarter 2020 Financial Results
7:05am
8-K
EX-99.2
xwh3qkf28vmh3c7
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
3o2qai 177
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
3vywbjl
6 Aug 20
Sutro Biopharma Reports Second Quarter 2020 Financial Results
7:03am
8-K
EX-99.1
gihsz2eh sh27f5qq
15 Jun 20
Regulation FD Disclosure
7:21am
8-K
EX-1.1
gzhb 8xjc
12 May 20
Entry into a Material Definitive Agreement
5:14pm
424B5
gqa12fcbk42suz2nw7c
12 May 20
Prospectus supplement for primary offering
5:02pm
8-K
EX-99.1
0w18awvwi
11 May 20
Sutro Biopharma Reports First Quarter 2020 Financial Results
4:27pm
424B5
0ntz4 xsohigbva
11 May 20
Prospectus supplement for primary offering
4:12pm